Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Free to healthcare providers. No ads, no sponsorships, no bias.

Intended for USA healthcare providers only.

Browse Clinical Trial Updates

All
ASCO Updates
Breast Cancer
GI Cancers
GU Cancers
GYN Oncology
Hematological Malignancies
Lung Cancer
Skin Cancer
Dr. Martin Dietrich reviews the evidence trastuzumab deruxtecan (T-Dxd) in gastric cancer (Video 2/3)

Dr. Martin Dietrich reviews the evidence trastuzumab deruxtecan (T-Dxd) in gastric cancer (Video 2/3)

T-Dxd in Gastric

Martin Dietrich
GI Cancers
Dr. Edgardo Santos discusses the emergence of SQ amivantamab+lazertinib in 1L EGFRm mNSCLC (Video 1/3)

Dr. Edgardo Santos discusses the emergence of SQ amivantamab+lazertinib in 1L EGFRm mNSCLC (Video 1/3)

MARIPOSA

Edgardo Santos, MD
Lung Cancer
Dr. Manali Kamdar discusses the curative potential of 2L CAR-T with liso-cel in R/R LBCL (Video 1/3)

Dr. Manali Kamdar discusses the curative potential of 2L CAR-T with liso-cel in R/R LBCL (Video 1/3)

Curative Potential of 2L CAR-T/liso-cel

Manali Kamdar, MD
Hematological Malignancies
Dr. Joshua Reuss reviews additional efficacy endpoints in treatment naïve population from the BEAMION trial of zongertinib in HER2m NSCLC (Video 2/3)

Dr. Joshua Reuss reviews additional efficacy endpoints in treatment naïve population from the BEAMION trial of zongertinib in HER2m NSCLC (Video 2/3)

BEAMION secondary efficacy

Joshua Reuss, MD
Lung Cancer
Dr. Himisha Beltran discusses a paradigm shift for BRCA2 mutations in prostate cancer (Video 1/3)

Dr. Himisha Beltran discusses a paradigm shift for BRCA2 mutations in prostate cancer (Video 1/3)

PARPi in BRCA2m Prostate Cancer

Himisha Beltran, MD
GU Cancers
Dr. Amer Zeidan discusses insights on anemia in lower-risk MDS and the use of luspatercept (Video 1/3)

Dr. Amer Zeidan discusses insights on anemia in lower-risk MDS and the use of luspatercept (Video 1/3)

Unmet need

Amer Zeidan, MD
Hematological Malignancies

Why subscribe?

  • Get one-minute, non-promotional, educational videos from distinguished thought leaders
  • Tailored to topics you select
    • Breast Cancer
    • Lung Cancer
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynecologic Cancers
    • Hemotologic Malignancies
    • Conference updates and more
  • No spam. No ads. No apps to download.
  • Always free and you can opt-out anytime if you feel this isn’t for you.

Fill out the form above to subscribe!

Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Intended for USA healthcare providers only.

If your institution is not listed, please input the Institution / Company name in the field below.

By clicking Subscribe, I agree that I have read and understand IDEOlogy Health’s Privacy Policy and Terms and Conditions and further agree to receive information from IDEOlogy Health and its companies

ideology-health
Privacy Policy
Terms of Service
Inc. 5000

IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.